PMID- 35871353 OWN - NLM STAT- MEDLINE DCOM- 20220908 LR - 20230328 IS - 1875-8908 (Electronic) IS - 1387-2877 (Print) IS - 1387-2877 (Linking) VI - 89 IP - 1 DP - 2022 TI - Reduced Hippocampal and Anterior Cingulate Expression of Antioxidant Enzymes and Membrane Progesterone Receptors in Alzheimer's Disease with Depression. PG - 309-321 LID - 10.3233/JAD-220574 [doi] AB - BACKGROUND: Major depressive disorder (MDD) is a risk factor for dementia including that caused by Alzheimer's disease (AD). Both MDD and AD have a higher prevalence in women than men, and estrogen-related processes have been implicated in this sex difference. OBJECTIVE: To identify if enhanced oxidative stress and decreased expression of the memory enhancer insulin-like growth factor 2 (IGF2), each implicated separately in MDD and AD, are exaggerated in individuals with both AD and MDD compared to those with AD. METHODS: Expression of target genes are determined by qPCR in postmortem hippocampus (Hip) and anterior cingulate cortex (ACC) of individuals with dementia and autopsy confirmed AD and those of AD+MDD. RESULTS: Transcript levels of the antioxidant enzymes catalase (CAT) and superoxide dismutase 1 (SOD1), as well as IGF2 and its receptor (IGF2R) were significantly lower in the Hip and ACC of individuals with both AD and MDD compared to those with AD and no MDD. Expressions of Progestin and AdipoQ Receptor Family Member 7 (PAQR7, alias progesterone receptor alpha, mPRa) and PAQR8 (mPRbeta), receptors that bind neurosteroids, were also lower in the Hip and ACC of AD+MDD samples compared to those of AD without MDD. Correlations among these transcripts revealed that estrogen receptor 2 (ESR2) and mPR beta are direct or indirect regulators of the expression of the antioxidant enzymes and IGF2R. CONCLUSION: Reduced levels of antioxidant enzymes, decreased IGF2 expression, and diminished estrogen or membrane progesterone receptor-dependent processes might be more pronounced in the subpopulation of individuals with AD and MDD than without MDD. FAU - Luo, Wendy AU - Luo W AD - Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. FAU - Pryzbyl, Katherine J AU - Pryzbyl KJ AD - Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. FAU - Bigio, Eileen H AU - Bigio EH AD - Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. FAU - Weintraub, Sandra AU - Weintraub S AD - Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. AD - Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. FAU - Mesulam, M-Marsel AU - Mesulam MM AD - Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. FAU - Redei, Eva E AU - Redei EE AD - Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. LA - eng GR - P30 AG072977/AG/NIA NIH HHS/United States GR - R21 AG062968/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - J Alzheimers Dis JT - Journal of Alzheimer's disease : JAD JID - 9814863 RN - 0 (Antioxidants) RN - 0 (Estrogens) RN - 0 (PAQR7 protein, human) RN - 0 (Receptors, Progesterone) RN - 4G7DS2Q64Y (Progesterone) SB - IM MH - *Alzheimer Disease/genetics/metabolism MH - Antioxidants/metabolism MH - Depression MH - *Depressive Disorder, Major/genetics MH - Estrogens MH - Female MH - Gyrus Cinguli/metabolism MH - Hippocampus/metabolism MH - Humans MH - Male MH - Progesterone/metabolism MH - Receptors, Progesterone/genetics/metabolism PMC - PMC10041688 MID - NIHMS1875875 OTO - NOTNLM OT - Antioxidant enzymes OT - depression OT - insulin like growth factor 2 OT - membrane progesterone receptor OT - molecular vulnerability OT - sex/gender differences COIS- CONFLICT OF INTEREST The authors have no conflict of interest to report. EDAT- 2022/07/25 06:00 MHDA- 2022/09/09 06:00 PMCR- 2023/03/27 CRDT- 2022/07/24 10:01 PHST- 2022/07/25 06:00 [pubmed] PHST- 2022/09/09 06:00 [medline] PHST- 2022/07/24 10:01 [entrez] PHST- 2023/03/27 00:00 [pmc-release] AID - JAD220574 [pii] AID - 10.3233/JAD-220574 [doi] PST - ppublish SO - J Alzheimers Dis. 2022;89(1):309-321. doi: 10.3233/JAD-220574.